このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Astec LifeSciences バランスシートの健全性
財務の健全性 基準チェック /26
Astec LifeSciencesの総株主資本は₹3.7B 、総負債は₹4.9Bで、負債比率は133.7%となります。総資産と総負債はそれぞれ₹9.7Bと₹6.1Bです。
主要情報
133.7%
負債資本比率
₹4.94b
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | ₹24.32m |
| エクイティ | ₹3.70b |
| 負債合計 | ₹6.05b |
| 総資産 | ₹9.75b |
財務の健全性に関する最新情報
Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28
Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
Nov 27Recent updates
Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested
Apr 17Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?
Apr 02Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?
Mar 18Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?
Mar 05Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?
Feb 20A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration
Feb 08Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?
Jan 28What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?
Jan 17
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 08I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Dec 28Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?
Dec 18Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?
Dec 07Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
Nov 27Ashok Hiremath Is The MD & Director of Astec LifeSciences Limited (NSE:ASTEC) And They Just Sold 35% Of Their Shares
Nov 17財務状況分析
短期負債: ASTECの 短期資産 ( ₹4.0B ) が 短期負債 ( ₹4.0B ) を超えています。
長期負債: ASTECの短期資産 ( ₹4.0B ) が 長期負債 ( ₹2.1B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: ASTECの 純負債対資本比率 ( 133% ) は 高い と見なされます。
負債の削減: ASTECの負債対資本比率は、過去 5 年間で86.6%から133.7%に増加しました。
債務返済能力: ASTECの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 2.1% )。
インタレストカバレッジ: ASTECの負債に対する 利息支払い が EBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。